CountryOfPapers CountryOfPapers
Journal list Promote
verified COP 17,5 · D1 • database Scopus / SJR & Web of Science indexed
Nature Reviews Drug Discovery
United Kingdom · Nature Research
workspace_premium D1 Top 10% — Drug Discovery lock Subscription

Nature Reviews Drug Discovery

Nature Reviews Drug Discovery is a monthly journal aimed at everyone working in the drug discovery and development arena. In addition to the highest-quality reviews and perspectives covering a broad scope, each issue includes news stories that investigate the hottest topics in dr...

ISSN: 1474-1776
Publisher: Nature Research
Category: Medicine (miscellaneous)
Indexation: verifiedScopus / SJR verifiedWeb of Science
COP Index trending_up
17,5 D1 Top 10%

1 of 128 journals in Drug Discovery

H-index · SJR 412 · 30,506
Acceptance rate pie_chart
16% Selective
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
NPD Subscription
Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

COP Index

17,5

D1 Top 10%

SJR Impact

30,506

H-index

412

Docs (year)

247

Docs 3y

718

Total refs

8808

Cites 3y

14603

Citable 3y

136

Cites/Doc 2y

16.64

Ref/Doc

35.66

Immediate OA

- €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Personalized cancer vaccines hit the spot

View more

When drugs unintentionally affect gut bugs

View more

Weeding out memory extinction

View more

Trends in development cycles

View more

The licensing gamble: raising the stakes

View more

The FDA needs you

View more

The early results of misfolding

View more

Vif - a new therapeutic target?

View more

Reducing cancer risk

View more

Pulling the plug on cancer

View more

Preventing metastatic relapse

View more

Piecing together a picture of stroke

View more
SHOW MORE ARTICLES

Regulating the beat

View more

Paralyzing the two-faced BOTOX

View more

Overcoming inhibition

View more

On the origin of transformative drugs

View more

Omalizumab

View more

New Safe Medicines Faster: a proposition for a pan-European research effort

View more

New forms of attack

View more

New directions in chemical space

View more

Neuropeptide gene polymorphisms and human behavioural disorders

View more

Moving towards early clinical trials for amyloid-targeted therapy in Alzheimer's disease

View more

Mining for bioinformatics jobs

View more

Look into the future

View more

FAQs